Bill Miller - Miller Value Partners,
Holding/activity history for Halozyme Therapeutics (HALO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q1 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2019 Q4 | 20,000 | 0.01 | $17.75 | $355,000 | SEC | ||
| 2019 Q3 | 20,000 | 0.01 | $15.50 | $310,000 | SEC | ||
| 2019 Q2 | 20,000 | 0.01 | $17.20 | $344,000 | SEC | ||
| 2019 Q1 | 20,000 | 0.01 | $16.10 | $322,000 | SEC | ||
| 2018 Q4 | 20,000 | 0.01 | Reduce 88.24% | 0.09 | $14.65 | $293,000 | SEC |
| 2018 Q3 | 170,000 | 0.10 | $18.17 | $3,089,000 | SEC | ||
| 2018 Q2 | 170,000 | 0.12 | $16.87 | $2,868,000 | SEC | ||
| 2018 Q1 | 170,000 | 0.15 | $19.59 | $3,330,000 | SEC | ||
| 2017 Q4 | 170,000 | 0.16 | $20.26 | $3,444,000 | SEC | ||
| 2017 Q3 | 170,000 | 0.14 | Reduce 82.10% | 0.44 | $17.37 | $2,953,000 | SEC |
| 2017 Q2 | 949,800 | 0.54 | Buy | 0.54 | $12.82 | $12,176,000 | SEC |